Ecovyst (ECVT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Sales increased 9.5% year-over-year to $200.1 million in Q2 2025, driven by higher sulfur costs pass-through, favorable pricing, and the acquisition of Waggaman sulfuric acid assets, but net income declined 27.7% to $6.0 million due to higher costs and lower volumes.
Adjusted EBITDA was $55.7 million, slightly down from $56.9 million a year ago, with a margin of 24.4%; Ecoservices segment was flat, while Advanced Materials & Catalysts declined.
Repurchased 2.9 million shares for $21.9 million in Q2 2025, reflecting a focus on shareholder value; $207.7 million remains under the buyback program.
Strategic review of Advanced Materials & Catalysts segment ongoing, with an update expected by mid-2025.
Integration of Waggaman assets progressing well, with expected synergies in 2026.
Financial highlights
Q2 2025 sales reached $200.1 million, up 9.5% year-over-year; Adjusted EBITDA was $55.7 million, down 2.1%; net income was $6.0 million, a 27.7% decrease; Adjusted EBITDA margin was 24.4%.
Ecoservices Q2 sales were $176.0 million (+14.4%), with Adjusted EBITDA at $49.8 million (flat year-over-year); Advanced Materials & Catalysts Q2 sales were $24.1 million (–16.6%), Adjusted EBITDA $13.7 million (–6.8%).
Zeolyst Joint Venture (50% share) Q2 sales were $28.4 million (–2.1%), with higher sustainable fuel catalyst sales offsetting lower hydrocracking and custom catalyst sales.
Adjusted Free Cash Flow for the first half was $(2) million, compared to $14 million in 2024, due to timing of JV dividends and higher capex.
Cash and cash equivalents at quarter end were $69.6 million, with total liquidity of $152 million.
Outlook and guidance
Full-year 2025 sales guidance raised to $795–$835 million, reflecting the Waggaman acquisition; Adjusted EBITDA guidance narrowed to $242–$254 million.
Adjusted Free Cash Flow guidance raised to $70–$80 million; capital expenditures projected at $80–$90 million.
Q3 2025 Adjusted EBITDA expected at $62–$72 million; Q4 guidance anticipates higher Ecoservices EBITDA and flat AM&C performance year-over-year.
Zeolyst JV sales guidance increased to $125–$140 million (50% share).
Leverage ratio expected to end 2025 around 3.5x, with a long-term target of 2x–2.5x.
Latest events from Ecovyst
- Strong 2025 growth, major divestiture, debt reduction, and robust 2026 outlook.ECVT
Q4 202526 Feb 2026 - Q2 2024 net income dropped 68% and guidance was lowered as catalyst demand softened.ECVT
Q2 20242 Feb 2026 - Strong demand, catalyst innovation, and sustainability drive growth and investment focus.ECVT
CL King's 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 3.4% to $179.2M, with resilient Ecoservices and steady full-year guidance.ECVT
Q3 202417 Jan 2026 - Q3 2024 saw robust cash flow, margin expansion, and a strategic focus on sustainability.ECVT
Bank of America Securities 2024 Leveraged Finance Conference12 Jan 2026 - Q4 growth in core segments, 2025 sales and EBITDA to rise despite Zeolyst JV impairment.ECVT
Q4 202423 Dec 2025 - $556M deal boosts catalyst capabilities, recurring revenue, and global reach.ECVT
M&A Announcement16 Dec 2025 - Annual meeting to vote on directors, pay, auditor, with focus on governance and sustainability.ECVT
Proxy Filing1 Dec 2025 - Q1 2025 sales up 1.1%, EBITDA down 14.5%, net loss $3.6M, guidance raised, key acquisition set.ECVT
Q1 202528 Nov 2025